Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Sarepta reported $328.7 million in total net product revenue for Q2 2026, down from $611.1 million in Q2 2025 due to lower ELEVIDYS sales and decreased collaboration revenues.
Tenaya reported positive interim data from MyPEAK-1 and RIDGE-1 clinical trials for TN-201 and TN-401 gene therapies, showing meaningful improvements in disease characteristics.
